Skip NavigationSkip to Content

Nanotechnology-Based Cancer Therapeutics-Promise and Challenge-Lessons Learned Through the NCI Alliance for Nanotechnology in Cancer

  1. Author:
    Farrell, D.
    Ptak, K.
    Panaro, N. J.
    Grodzinski, P.
  2. Author Address

    [Farrell, Dorothy; Ptak, Krzysztof; Grodzinski, Piotr] NCI, Ctr Strateg Sci Initiat, Off Director, NIH, Bethesda, MD 20892 USA. [Panaro, Nicholas J.] NCI, Nanotechnol Characterizat Lab, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21702 USA.;Grodzinski, P, NCI, Ctr Strateg Sci Initiat, Off Director, NIH, Bethesda, MD 20892 USA.;grodzinp@mail.nih.gov
    1. Year: 2011
    2. Date: Feb
  1. Journal: Pharmaceutical Research
    1. 28
    2. 2
    3. Pages: 273-278
  2. Type of Article: Article
  3. ISSN: 0724-8741
  1. Abstract:

    The new generation of nanotechnology-based drug formulations is challenging the accepted ways of cancer treatment. Multi-functional nanomaterial constructs have the capability to be delivered directly to the tumor site and eradicate cancer cells selectively, while sparing healthy cells. Tailoring of the nano-construct design can result in enhanced drug efficacy at lower doses as compared to free drug treatment, wider therapeutic window, and lower side effects. Nanoparticle carriers can also address several drug delivery problems which could not be effectively solved in the past and include reduction of multi-drug resistance effects, delivery of siRNA, and penetration of the blood-brain-barrier. Although challenges in understanding toxicity, biodistribution, and paving an effective regulatory path must be met, nanoscale devices carry a formidable promise to change ways cancer is diagnosed and treated. This article summarizes current developments in nanotechnology-based drug delivery and discusses path forward in this field. The discussion is done in context of research and development occurring within the NCI Alliance for Nanotechnology in Cancer program.

    See More

External Sources

  1. DOI: 10.1007/s11095-010-0214-7
  2. WOS: 000286602000007

Library Notes

  1. Fiscal Year: FY2010-2011
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel